BRG1/SMARCA4 is mutationally inactivated or epigenetically silenced in non-small-cell lung cancer (NSCLC), medulloblastoma, and Burkitt’s lymphoma51–53. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.